Bulletin
Investor Alert

Landos Biopharma Inc.

NAS: LABP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 14, 2021, 4:01 p.m.

/zigman2/quotes/224337277/composite

$

11.65

Change

0.00 0.00%

Volume

Volume 419

Quotes are delayed by 20 min

/zigman2/quotes/224337277/composite

Previous close

$ 10.20

$ 11.65

Change

+1.45 +14.22%

Day low

Day high

$10.08

$12.19

Open

52 week low

52 week high

$8.82

$16.99

Open

Annual Financials for Landos Biopharma Inc.

Fiscal year is January-December. All values USD millions. 201820192020 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A --80,000103,000137,000
COGS excluding D&A -----
Depreciation & Amortization Expense --80,000103,000137,000
Depreciation --80,000103,000137,000
Amortization of Intangibles -----
Gross Income --(80,000)(103,000)(137,000)
201820192020 5-year trend
SG&A Expense --7.86M13.19M30.54M
Research & Development --6.8M11.81M25.34M
Other SG&A --1.06M1.38M5.2M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense --(106,000)127,000532,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --4,000304,000-
Gross Interest Expense --4,000304,000-
Interest Capitalized -----
Pretax Income --(8.05M)(13.47M)(30.14M)
Income Tax --(2.01M)--
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits --2.01M--
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income --(6.04M)(13.47M)(30.14M)
Minority Interest Expense -----
Net Income --(6.04M)(13.47M)(30.14M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries --(6.04M)(13.47M)(30.14M)
Preferred Dividends -----
Net Income Available to Common --(6.04M)(13.47M)(30.14M)
EPS (Basic) --(0.15)(0.34)(0.75)
Basic Shares Outstanding --40.1M40.1M40.12M
EPS (Diluted) --(0.15)(0.34)(0.75)
Diluted Shares Outstanding --40.1M40.1M40.12M
EBITDA --(7.86M)(13.19M)(30.54M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.